UK Biotechs Get Share Of £1bn Coronavirus Support Fund
Payments Must Not Be Delayed, Says BIA
Small-to-medium non-profit making UK biotechs will be supported via loans and grants, but government unmoved by Tax Credits suggestion for whole sector.
You may also be interested in...
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
CD47 was once seen as one of the hottest properties in immunotherapy, but multiple setbacks have tempered enthusiasm for targeting the ‘don’t eat me’ cell surface protein. I-Mab and Gilead are just two casualties.
The ex-chief medical officer at Novartis is now CEO at the UK-based biotech, which he he told Scrip could have a ‘transformational’ therapy to protect patients after a heart attack.